$CTEV News

Claritev Appoints Jennifer Main to its Board of Directors

Claritev Corporation Announces Third Quarter 2026 Earnings Conference Call

Claritev: Revenue Growth Is Back, Cash Flow Is The Next Test

Claritev Selected by GDIT to Support CDC’s World Trade Center Health Program

Claritev Selected By General Dynamics Information Technology To Support The World Trade Center Health Program; Terms Not Disclosed

Claritev Releases 2025 Corporate Responsibility Report

Claritev Corporation (CTEV) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Claritev Appoints Ben Letham to its Board of Directors

Claritev Cares Helps Rural Patients Get Critical Care Closer to Home

Claritev’s (CTEV) Profit Picture Brightens, But Its Cash Cushion Shrinks

Claritev (CTEV) Price Target Increased by 21.68% to 46.75

Claritev Corporation Announces Participation in Upcoming Events

Barclays Maintains Overweight on Claritev, Raises Price Target to $40

Claritev (CTEV) Q2 2026 Earnings Call Transcript

Claritev (CTEV) Stock Fair Value Rises After Analysts Weigh Growth Against Leverage Risks

Wells Fargo Maintains Equal-Weight on Claritev, Raises Price Target to $30

Claritev Analysts Raise Their Forecasts Following Q2 Earnings

Citigroup Maintains Buy on Claritev, Raises Price Target to $45

Canaccord Genuity Maintains Buy on Claritev, Raises Price Target to $43

Claritev Corporation Q2 2026 Earnings Call Summary